T he enzyme telomerase maintains the length of specialized repetitive structures called telomeres, which are found at the ends of chromosomes. When they become damaged or shortened, telomeres can stop cells from dividing 1 . Most cells in adult humans have very low or undetectable levels of telomerase and relatively short telomeres, and therefore have a limited ability to replicate 2 . However, elevated telomerase levels are seen in various animal and human stem cells that must retain their replicative capacity for self-renewal 3 . Telomerase defects are associated with tissue scarring (fibrosis) in the livers of both mice and humans 4, 5 , but which cells in the liver express telomerase, and whether they act as stem cells, has been unclear. On page 244, Lin et al. 6 characterize this cell population in mice.
First, the authors identified telomeraseexpressing cells in the mouse liver and tracked descendent cells. The group genetically engineered mice to contain a modified version of the gene Tert, which encodes a subunit of telomerase. When the mice are treated with a drug, this alteration causes cells expressing Tert to be indelibly labelled by a fluorescent protein. Once the genetically modified cells are triggered in this way, they and all their descendants produce the fluorescent protein, even if the cells no longer express Tert itself.
Lin et al. found that 3-5% of hepatocytes, the most prevalent type of cell in the liver, fluoresce in response to drug treatment. The authors confirmed, by quantitation of messenger RNA levels, that these cells express Tert. Next, they examined the livers of adult mice one year after drug treatment. The initially labelled cells (dubbed Tert High ) had given rise to clusters of descendants dispersed throughout the liver's lobes, making up about 30% of the liver's total mass (Fig. 1) Data  Fig. 2 in ref. 4) .
Thornalley and colleagues' strategy is more of a bottom-up approach: they use a proxy for deep-water current strength to measure AMOC strength more directly than do Caesar and co-workers. The weaknesses of this approach are that it accounts for only the local bottom currents at the sites from which the cores are taken, which might not capture the entire AMOC system, and that it could be susceptible to local nonlinear effects such as abrupt shifts in the position of the current. However, Thornalley et al. show that there is a striking correlation between their grain-size proxy and the measured density of the Labrador Sea Water (a major component of the North Atlantic Deep Water), as well as with the heat content of the subpolar gyre; these correlations shore up the bridge that links their localized proxy measurements to broader-scale changes in the AMOC.
For now, the timing of the AMOC decline remains a source of intrigue. Future studies that provide a moredetailed spatial network of multiple proxy reconstructions will help to clarify some of the remaining ambiguity about which elements of the AMOC were changing and when. It is -at least scientifically -reassuring to see that the present two studies converge on the conclusion that the modern AMOC is in a relatively weak state. However, in the context of future climate-change scenarios and a possible collapse in the AMOC 11 In the future, it will be crucial to assess how relevant these findings in mice are to human liver regeneration. The fact that ablation of Tert
High hepatocytes results in fibrosis in the injured mouse liver seems to support relevance for humans, because people who harbour mutations in TERT and genes that encode other telomere-related factors can also exhibit fibrosis and cirrhosis (the latter being a predictor of liver cancer) 5 . However, Tert High hepatocytes have not been seen in human livers -although the possibility has not yet been assessed with the sensitivity of the genetic-labelling approach used in mice by Lin and colleagues. An alternative explanation for diseases in humans who have telomerase-related mutations is that excessive telomere shortening in early development might affect many organ progenitors in a nonspecific way.
More-detailed studies in humans will be needed to confirm how telomerase-based regeneration forestalls liver disease, and possibly liver cancer. Nevertheless, Lin and colleagues' study provides insight into a previously unidentified, dispersed-cell mode of liver regeneration. ■ 
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